These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37625937)

  • 21. [Psychopathology of the misuse of Subutex®: The Popeye syndrome].
    Békaert J; Podevin G
    Encephale; 2015 Jun; 41(3):229-37. PubMed ID: 25212472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
    Bachireddy C; Bazazi AR; Kavasery R; Govindasamy S; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2011 Jul; 116(1-3):151-7. PubMed ID: 21232882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stigma from the Viewpoint of the Patient.
    Woods JS; Joseph H
    J Addict Dis; 2015; 34(2-3):238-47. PubMed ID: 26076048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
    Shulman M; Wai JM; Nunes EV
    CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
    Lofwall MR; Walsh SL; Nunes EV; Bailey GL; Sigmon SC; Kampman KM; Frost M; Tiberg F; Linden M; Sheldon B; Oosman S; Peterson S; Chen M; Kim S
    JAMA Intern Med; 2018 Jun; 178(6):764-773. PubMed ID: 29799968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice].
    Dupouy J; Bez J; Barsony J; Oustric S; Lapeyre-Mestre M
    Therapie; 2013; 68(3):155-61. PubMed ID: 23886460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment.
    Binder P; Messaadi N; Perault-Pochat MC; Gagey S; Brabant Y; Ingrand P
    J Addict Dis; 2016; 35(2):101-8. PubMed ID: 26745033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stage I pilot study of acceptance and commitment therapy for methadone detoxification.
    Stotts AL; Green C; Masuda A; Grabowski J; Wilson K; Northrup TF; Moeller FG; Schmitz JM
    Drug Alcohol Depend; 2012 Oct; 125(3):215-22. PubMed ID: 22425411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?
    Vanderkam P; Gagey S; Ingrand P; Perault-Pochat MC; Brabant Y; Blanchard C; Tudrej B; Messaadi N; Binder P
    Drug Alcohol Depend; 2018 Jul; 188():10-15. PubMed ID: 29727755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internalized stigma among patients with substance use disorders at a tertiary care center in India.
    Sarkar S; Balhara YPS; Kumar S; Saini V; Kamran A; Patil V; Singh S; Gyawali S
    J Ethn Subst Abuse; 2019; 18(3):345-358. PubMed ID: 28898165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.
    Stein MD; Conti MT; Herman DS; Anderson BJ; Bailey GL; Noppen DV; Abrantes AM
    Am J Addict; 2019 Jul; 28(4):270-276. PubMed ID: 30993833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.
    Cushman PA; Liebschutz JM; Anderson BJ; Moreau MR; Stein MD
    J Subst Abuse Treat; 2016 Sep; 68():68-73. PubMed ID: 27431049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium.
    Fraeyman J; Symons L; Van Royen P; Van Hal G; Peremans L
    Eur J Gen Pract; 2016 Jun; 22(2):134-40. PubMed ID: 26799738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Past-year gambling behaviour among patients receiving opioid substitution treatment.
    Castrén S; Salonen AH; Alho H; Lahti T; Simojoki K
    Subst Abuse Treat Prev Policy; 2015 Jan; 10():4. PubMed ID: 25626451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.